1. What is the decision or change (e.g. clinical topic, practice guideline, system design, delivery of care) you are facing or struggling with where a summary of the evidence would be helpful?
Question: The spike proteins the body is forced to produce following mRNA injections are shown to be present at least 15 months post injection. The mRNA injections also cause a variety of short and long term health complications, including suppressed immune system, increased vulnerability to the SARS-CoV-2 virus, blood clots, heart damage, increased risk of stroke, increased risk of cancer, and many others. Nattokinase has been shown to inhibit function of the spike protein. If taken for 4-5 months (long enough for all the infected blood cells to die), will patients recover from the injection, stop producing the spike protein, and lower their risk of other complications associated with the injections?
Population: Recipients of any generation or formulation of Pfizer's or Moderna's mRNA injections.
Intervention and comparator: Nattokinase vs placebo vs any other potential therapies.
Outcomes: Prevalence of spike protein in patients' blood and prevalence of complications from mRNA injections, before and after treatment, compared between all groups.
Overall: What is the effectiveness of Nattokinase for recipients of the mRNA injections for helping their bodies recover from the injections?
2. Why are you struggling with this issue?
The mRNA investigative new drugs were forced on many people before any safety data was available. Many people have suffered, and continue to suffer, great harm from these injections. The continued presence of the spike protein more than a year after injection suggests the injection is acting as an infectious disease within their system. Given the purpose of the spike protein to anchor to blood cells and allow the virus to infect them, it is likely responsible for a large portion of the complications. If the spike protein can be prevented from infecting other cells, it may eventually get filtered out of their systems, allowing their body to start the recovery process.
This is also an issue with people who did not get the injections, as there is a strong possibility the spike proteins will allow infection of blood transfusion recipients if the blood donor had received an mRNA injection. For this reason, there are many people who are now refusing blood transfusions unless they can do a direct donation from someone they know is safe. Population scale treatment of mRNA recipients can greatly reduce this risk and reinstill some confidence in the safety of receiving blood from the blood bank.
3. What do you want to see changed? How will you know that your issue is improving or has been addressed?
I want studies conducted investigating ways to stop the harmful effects of the mRNA injections and help remove the harmful spike protein from recipients' systems.
4. When do you need the evidence report?
Thu, 01/01/2026
5. What will you do with the evidence report?
- I will tell my friends and family about the availability of a product to help them heal from the mRNA injections.
- I will terminate my advance medical directive to not administer blood transfusions to me.
Supporting Documentation
Article (PDF, 1.2 MB)
Optional Information About You
What is your role or perspective? Patient/consumer
May we contact you if we have questions about your nomination? Yes
